Results 161 to 170 of about 663,256 (217)

A CT-based radiomics model for predicting progression-free survival in patients with epithelial ovarian cancer. [PDF]

BMC Cancer
Leng Y, Zhou J, Liu W, Luo F, Peng F, Gong L.   +5 more
europepmc   +1 more source

Stereotactic body radiation therapy in oligometastatic pancreatic cancer: overall survival improvement and <i>SMAD4</i> as a predictor of progression-free survival. [PDF]

J Gastrointest Oncol
Elhariri A, Patel J, Mahadevia H, Modi K, Albelal D, Majeed U, Jones JC, Borad MJ, Tran NH, Rutenberg MS, Babiker H.   +10 more
europepmc   +1 more source

Erratum: Predicting the survival probability of functional neuroendocrine tumors treated with peptide receptor radionuclide therapy: Serbian experience

Frontiers in Endocrinology
Frontiers Production Office
doaj   +1 more source

Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy. [PDF]

Sci Rep
Singh A, Horng H, Roshkovan L, Hershman M, Cohen EA, Aggarwal C, Carpenter EL, Katz SI, Kontos D.   +8 more
europepmc   +1 more source

Analysis of factors influencing tumor volume doubling time in hepatocellular carcinoma and its predictive value for progression-free survival. [PDF]

Sci Rep
Huang T, Chen Y.
europepmc   +1 more source

Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data. [PDF]

BMC Cancer
Kortüm M, Theurich S, Farrell J, Jackson G, Cook G, Cappelleri JC, Ashman O, Neff-Baro S, Gauthier A, Jewiti-Rigondza K, Sidhom A, Chaudhary A, Scheid C.   +12 more
europepmc   +1 more source

Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study. [PDF]

J Pharm Health Care Sci
Isezaki T, Yuyama H, Yasumuro O, Miyaji Y, Funakoshi R.   +4 more
europepmc   +1 more source

Low-dose glucocorticoid improves progression-free survival of children with B cell acute lymphoblastic leukaemia following chimeric antigen receptor T-cell therapy. [PDF]

Front Immunol
Zhang H, Wang Y, Ji Q, Zhang Q, Qiu C, Huang S, Dong X, Pan J, Lu J, Bai Z, Hu S, Wu S.   +11 more
europepmc   +1 more source

The Value of Baseline [¹⁸F]FDG-PET in Predicting the Progression-Free Survival in Patients with Thymic Epithelial Tumours: A Systematic Review and Meta-Analysis. [PDF]

Diagnostics (Basel)
Miceli A, Librando M, Dondi F, Jonghi-Lavarini L, D'Antonio A, Mura A, Nappi AG, Rovera G, De Feo MS, Santo G, Lanfranchi F.   +10 more
europepmc   +1 more source